Indian Heart Journal (Nov 2020)

Cost-consequence analysis (CCA) of sacubitril/valsartan versus angiotensin converting enzyme inhibitors (ACEi) in chronic heart failure patients with reduced ejection fraction (HFrEF) in Indian healthcare setting

  • Sameee Bhasker Gokale,
  • Gauri Billa,
  • Sushant Anand,
  • Sanchit Nanda

Journal volume & issue
Vol. 72
pp. S21 – S22

Abstract

Read online

No abstracts available.